JAMDA
Volume 11, Issue 1 , Pages 33-41, January 2010

Prevalence and Severity of Chronic Kidney Disease and Anemia in the Nursing Home Population

  • William M. McClellan, MD, MPH

      Affiliations

    • Department of Epidemiology, Emory University, Atlanta, GA
    • Corresponding Author InformationAddress correspondence to William M. McClellan, MD, MPH, Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd., Atlanta, GA 30322.
  • ,
  • Barbara Resnick, PhD

      Affiliations

    • University of Maryland School of Nursing, Baltimore, MD
  • ,
  • Lei Lei, PhD

      Affiliations

    • Department of Biostatistics & Epidemiology, Amgen, Inc., Thousand Oaks, CA
  • ,
  • Brian D. Bradbury, MA, DSc

      Affiliations

    • Department of Biostatistics & Epidemiology, Amgen, Inc., Thousand Oaks, CA
  • ,
  • Angela Sciarra, PharmD

      Affiliations

    • Department of Clinical Development, Amgen, Inc., Thousand Oaks, CA
  • ,
  • Reshma Kewalramani, MD

      Affiliations

    • Department of Clinical Development, Amgen, Inc., Thousand Oaks, CA
  • ,
  • Joseph G. Ouslander, MD

      Affiliations

    • Charles E. Schmidt College of Biomedical Science and Christine E. Lynn College of Nursing, Florida Atlantic University, Boca Raton, FL
    • Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL

published online 09 November 2009.

Objectives

Chronic kidney disease (CKD) is an emerging health concern and may have important implications for the management of older people with many other chronic conditions, such as the nursing home (NH) resident population. This study was designed to describe the prevalence of CKD and associated comorbidities in a representative sample of NH residents.

Design

Cross-sectional descriptive study as a component of a prospective observational study of CKD and anemia in the NH population.

Setting

Eighty-two geographically representative NHs in the United States.

Participants

Participants were 794 NH residents who had complete baseline data collected.

Measurements

Residents for whom consent was obtained underwent a record review focused on identifying a predefined set of comorbid conditions, clinical assessment, and blood and urine collections. Stage of CKD was based on estimated GFR (eGFR) using the MDRD equation: no CKD (eGFR > 60mL/min/1.73m2), Stage 3a (45–59), Stage 3b (30–44), and Stage 4/5 (< 30).

Results

Consent was obtained from 847 of 1626 residents screened; 32 were ineligible and 21 dropped out of the study; complete data were available for 794 residents. CKD was present in approximately 50% of residents; of these residents with CKD, 47.6% were stage 3a, 39.27% stage 3b, and 13.2% stage 4/5. Fifty percent of the population had anemia, and anemia was more common in those with CKD. The average number of comorbid conditions in the population was 5.3 (SD 2.2); the proportion of patients with multiple comorbid conditions, especially cardiovascular conditions, increased with increasing stage of CKD. Among those without CKD, 57% had 5 or more comorbidities in comparison to 87% of those with stage 4/5 CKD.

Conclusions

In this representative sample of 794 US NH residents, 50% had clinical evidence of CKD. Patients with CKD, particularly those at later stages, were more likely to have cardiovascular comorbidities and anemia. The co-occurrence of these conditions in institutionalized populations may have important implications for the clinical management of this patient population, particularly as it relates to the potential for further renal complications.

Keywords: Nursing home, chronic kidney disease, cardiovascular disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 B.D.B., L.L., A.S., and R.K. are employees of Amgen. J.G.O. served as a paid consultant to Amgen to help design and implement the project reported in this article, and has received an educational grant from Amgen.

PII: S1525-8610(09)00250-3

doi:10.1016/j.jamda.2009.07.003

JAMDA
Volume 11, Issue 1 , Pages 33-41, January 2010